The latest news effecting cancer patients and oncology service delivery during the COVID-19 pandemic
By Professor Craig Underhill. The COVID-19 pandemic has not only reshaped our daily lives but has also revolutionised the landscape of clinical trials, improving equity of access for patients with cancer. This was the focus of our study recently published in JAMA Oncology. The study highlights the significant uptake of digital technologies in clinical trial conduct, particularly emphasising the emergence of telehealth consultations and decentralised clinical trials (DCT). As face-to-face interactions became limited due to pandemic restrictions, the healthcare sector rapidly embraced digital solutions to ensure continuity in patient care and trial operations. This surge in digital adoption, driven by…